Regulators, EMA and HMA, have published principles and recommendations on the use of LLMs, which are being increasingly used ...

For the pharmaceutical industry, drug formulation is a cornerstone, crucial for converting bioactive molecules into effective ...

In episode 1, cell and gene therapy experts Dr. Fabian Gerlinghaus, Dr. Claudia Zylberberg, and Benjamin McLeod weigh in on hot topics in CGT. Buy, Sell, Hold is a rapid-fire expert panel covering a ...

Pharmaceutical packaging must advance to adapt to new, complex modalities. Suitable packaging for pharmaceutical products is a must to ensure the integrity of the products is maintained, which ...

Pharmaceutical Technology Europe spoke with John McQuaid, president and managing director at Almac Pharma Services, at CPHI Milan 2024, held October 8–10, in Milan, Italy, about how the pharmaceutical ...

SK pharmteco will be the preferred manufacturing partner for AVG-101, AaviGen’s lead gene therapy product. The California-based contract development and manufacturing organization (CDMO) SK pharmteco, ...

The draft joint network strategy for the EU until 2028 will be open for public consultation until Nov. 30, 2024. The European Medicines Agency (EMA) and the Heads of Medicines Agency (HMA) announced ...

Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory ...

Enzene Biosciences CEO Himanshu Gadgil talked about fully connected continuous manufacturing's role in providing equity for biotech companies that may not normally be able to afford such services. As ...

Nicolas Camper, senior director—Bioconjugation Chemistry, Abzena, discussed new advancements in ADC technologies, including the role of complex chemistries. Pharmaceutical Technology® Europe spoke ...

Five speakers discussed the impact of the COVID-19 pandemic, the rise of artificial intelligence, more women in leadership tracks in the industry, and various emerging technologies. On the final day ...